Adults aged 30 to 69 in Brazil face a stark toll from industrially formulated foods: a modeling study estimates that ultra-processed food intake accounts for roughly one-third of premature cardiovascular disease deaths in that age group. The finding, published in Frontiers in Nutrition, applies comparative risk assessment methods to national dietary and mortality data, projecting thousands of attributable deaths, incident cases, and disability-adjusted life years each year. As global consumption of these products climbs, the results sharpen a growing debate over whether targeted dietary policy can meaningfully reduce heart disease burden within a few years.
Why the link between processed foods and heart deaths demands attention now
Heart disease remains the leading killer worldwide, and the share of calories people consume from ultra-processed products has risen steadily across many middle-income countries. Brazil offers a useful test case because national dietary surveys track consumption patterns in detail, and the country already has one of the most advanced food-labeling frameworks in Latin America. The modeling work in Brazilian adults used those surveys alongside cause-of-death registries to estimate how many premature cardiovascular events, including coronary heart disease and stroke, can be statistically attributed to current ultra-processed food intake levels among adults 30 to 69.
For policymakers, the practical question is whether reducing that intake would show up in hospital records fast enough to justify aggressive regulation. A plausible hypothesis holds that a 20 percent reduction in the ultra-processed food share of total energy intake could produce measurable declines in coronary heart disease incidence within five years in urban populations, provided researchers can link supermarket purchase data to hospital admission records. Brazil already collects both datasets at scale. If the modeling estimates are even directionally correct, the policy payoff from linking those data streams would be significant, giving regulators a feedback loop between dietary intervention and clinical outcome.
How researchers quantified ultra-processed food deaths in Brazil
The study’s architecture rests on two pillars: exposure data from national dietary surveys that capture how much of the average Brazilian adult’s caloric intake comes from ultra-processed products, and relative risk estimates drawn from pooled meta-analyses of cohort studies. The researchers used the NOVA classification system, which categorizes foods by degree and purpose of industrial processing rather than by nutrient content alone. Under NOVA, ultra-processed products are industrial formulations built largely from substances derived from foods and additives, with little or no intact food in the final product.
For the risk functions, the Brazil team drew on a systematic review and meta-analysis in the British Journal of Nutrition, which pooled relative risks linking high ultra-processed food consumption to cardiovascular outcomes including coronary heart disease and cerebrovascular disease; that quantitative synthesis supplied the dose-response parameters fed into the comparative risk assessment model. By combining exposure prevalence with those pooled risk ratios and age-specific mortality rates, the researchers estimated the fraction of premature cardiovascular deaths, new cases, and disability-adjusted life years attributable to ultra-processed food consumption each year.
The study also modeled reduction scenarios, projecting how many deaths and cases could be averted if the population shifted a portion of ultra-processed calories toward minimally processed alternatives. The investigators used their comparative risk framework to simulate relative changes in disease burden under different intake levels, effectively asking how cardiovascular mortality would look if Brazilians derived less of their daily energy from ultra-processed products and more from basic staples and freshly prepared meals.
To make those projections transparent, the authors presented uncertainty intervals around each estimate, reflecting statistical imprecision in both exposure and risk inputs. The detailed assumptions, from baseline intake distributions to scenario definitions, are laid out in the technical appendix, which also reports age- and sex-specific results. These tables show that attributable fractions are not uniform: in some subgroups, especially middle-aged men, the modeled share of cardiovascular deaths linked to ultra-processed foods is even higher than the overall estimate.
Separate from the Brazil-specific model, a broader evidence base has accumulated around ultra-processed diets and cardiovascular risk. Multiple cohort studies in different countries have reported elevated rates of heart disease and stroke among people in the highest consumption categories compared with those who eat fewer ultra-processed products. Meta-analyses pooling these cohorts generally find a graded association, with risk rising across intake quartiles or quintiles. While effect sizes vary, the consistency of direction across populations strengthens the case that the Brazilian estimates are not an outlier but part of a wider pattern.
Gaps in the evidence and what to watch next
The most important limitation is that the Brazil study is a model, not a direct observation of what happens when people change their diets. Comparative risk assessment can estimate attributable burden under current conditions and project what might happen under alternative scenarios, but it cannot confirm that removing ultra-processed foods from real diets will produce the predicted decline in heart disease events. No large-scale intervention trial has yet tested that proposition over a multi-year period with hard cardiovascular endpoints such as myocardial infarction or cardiovascular death.
Shorter-term feeding studies do suggest biological mechanisms that could plausibly connect ultra-processed diets to cardiovascular risk. Experimental work has reported effects on body weight, blood pressure, lipid profiles, and markers of inflammation when participants consume highly processed menus compared with minimally processed alternatives, even when macronutrient content is similar. However, these trials are small and brief, often lasting only weeks, and cannot directly inform long-term event rates. They do, however, support the idea that processing-related characteristics-such as energy density, texture, and additive load-may influence appetite regulation and metabolic health beyond simple nutrient counts.
Geographic scope is another constraint. The modeling relies on Brazilian dietary survey data and Brazilian mortality registries. Whether the same attributable fractions apply in the United States, India, or Nigeria depends on local consumption patterns, baseline cardiovascular risk profiles, and the specific ultra-processed products available in each market. Product reformulation, fortification policies, and cultural eating habits all shape how ultra-processed foods interact with health. No comparable modeling study has yet been published for other large populations using identical methods, which means the “nearly a third” estimate should be understood as specific to Brazil’s adult population rather than a universal figure.
There is also an ongoing scientific debate over how precisely to define ultra-processed foods and whether the NOVA framework captures the most health-relevant dimensions of processing. Critics argue that grouping all industrial formulations together may obscure important differences between products, such as whole-grain breads versus sugary beverages. Supporters counter that the classification reflects real-world dietary patterns, where high ultra-processed intake often clusters with other risk factors and displaces traditional meals built around minimally processed staples. How future studies refine or replace NOVA will influence both exposure assessment and policy recommendations.
For policymakers in Brazil, the immediate implication of the modeling work is that even modest shifts away from ultra-processed products could yield meaningful reductions in cardiovascular burden within a politically relevant timeframe. Front-of-pack warning labels, marketing restrictions to children, fiscal measures, and public procurement standards are all tools that could nudge consumption patterns. Crucially, the same data streams used in the current analysis-national dietary surveys and mortality registries-could be leveraged to monitor whether such policies are followed by measurable changes in intake and disease rates.
For other countries watching Brazil, the study offers a template rather than a one-size-fits-all estimate. Replicating the modeling approach with local data would allow governments to quantify their own attributable burdens and evaluate the potential payoff of dietary policies alongside more traditional cardiovascular prevention strategies like tobacco control and hypertension treatment. As ultra-processed products continue to expand their global market share, the question is no longer whether they matter for heart health, but how quickly and decisively public health systems will respond to the accumulating evidence.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
